ATS Medical, Inc. Announces Third Quarter 2007 Earnings Release Date and Conference Call

MINNEAPOLIS, Oct. 29 /PRNewswire-FirstCall/ -- ATS Medical, Inc. , manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that it will release financial results for the third quarter ended September 30, 2007 after the market close on Monday, November 5, 2007. The Company will host a conference call and webcast on Monday, November 5, 2007 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the Company’s third quarter results and current corporate developments. The dial-in number for the conference call is 800-240-6709 for domestic participants and 303-262-2140 for international participants.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will remain available for seven days. The replay can be accessed by dialing 800-405-2236 for domestic participants and 303-590-3000 for international participants, using the passcode 11098124#. A live webcast of the call can be accessed at http://www.atsmedical.com by clicking on the Investors icon. The webcast will also be archived on the company’s website.

About ATS Medical

ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The company, global in scope, is headquartered in Minneapolis, Minnesota. More than 140,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3f(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical’s focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(R) annuloplasty products for heart valve repair, ATS CryoMaze(TM) surgical ablation products, and RTI-Cardiovascular for allograft tissue services. The ATS Medical web site is http://www.atsmedical.com.

CONTACT: Michael Dale, President, CEO, +1-763-553-7736, or Michael Kramer,
CFO, +1-763-557-2222, both of ATS Medical, Inc.; or investors, Jennifer
Beugelmans, +1-646-201-5447, Doug Sherk, +1-415-896-6820, or media,
Jennifer Saunders, +1-646-201-5431, all for ATS Medical, Inc.

Web site: http://www.atsmedical.com//

MORE ON THIS TOPIC